{"id":"W4207010819","doi":"10.1016/j.jtct.2022.01.017","title":"Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research","year":2022,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"Janssen Pharmaceuticals; National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Heart, Lung, and Blood Institute; U.S. Public Health Service; Health Resources and Services Administration; U.S. Food and Drug Administration; Astellas Pharma; Daiichi-Sankyo; Bayer Fund; Kiadis Pharma; TG Therapeutics; Medical College of Wisconsin; Chimerix; Jazz Pharmaceuticals; Takeda Pharmaceuticals U.S.A.; AbbVie; Merck; Spectrum Pharmaceuticals; National Cancer Institute; Gilead Sciences; Karyopharm Therapeutics; Novartis; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Amgen; Falk Foundation; CareDx; Amyloidosis Foundation; Pfizer; Alexion Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Internal medicine; Hazard ratio; Transplantation; Prolymphocytic leukemia; Regimen; Cumulative incidence; Gastroenterology; Hematopoietic stem cell transplantation; Alemtuzumab; Oncology; Confidence interval; Leukemia; Surgery; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001115052,0.0002272584,0.0003562735,0.0009432826,0.0002962787,0.0006778871,0.0003597245,0.000307105,0.0006299711],"category_scores_gemma":[0.001802516,0.0001808444,0.0005071989,0.001766263,0.0003455534,0.000623914,0.0007380114,0.0006010076,0.0001313858],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004700646,"about_ca_system_score_gemma":0.000475631,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003255846,"about_ca_topic_score_gemma":0.003336702,"domain_scores_codex":[0.9993607,0.0001505465,0.00008100813,0.0001540932,0.0001595202,0.00009415255],"domain_scores_gemma":[0.9983447,0.0003083451,0.0008393176,0.0001360405,0.0001543988,0.0002173211],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001002043,0.00001548202,0.9978939,0.00000819246,0.00006763203,0.0000393727,0.00003702584,0.00005790753,0.0000801655,0.00002517016,0.0001359227,0.001539048],"study_design_scores_gemma":[0.00000913746,0.00004252547,0.9990387,0.000006295568,0.0000633812,0.0001909445,0.0001142243,0.0002063827,0.0000384809,0.00002823674,0.0002580236,0.000003634135],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984466,0.0006983707,0.0000743999,0.00007781391,0.000004216436,0.000004879262,0.0004337875,0.000002001017,0.0002579243],"genre_scores_gemma":[0.998378,0.0004619795,0.00003743003,0.00004212061,0.00002393329,0.000006054067,0.00101513,0.00000228468,0.00003293786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003255846,"threshold_uncertainty_score":0.00647378,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0394564369277786,"score_gpt":0.3046050989104168,"score_spread":0.2651486619826382,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}